![]() |
Volumn 352, Issue 6291, 2016, Pages 1275-1276
|
Outsourcing the immune response to cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
MUTANT PROTEIN;
T LYMPHOCYTE RECEPTOR;
EPITOPE;
HLA A2 ANTIGEN;
LYMPHOCYTE ANTIGEN RECEPTOR;
TUMOR ANTIGEN;
ANTIBODY;
ANTIGEN;
CANCER;
CELLS AND CELL COMPONENTS;
DISEASE TREATMENT;
IMMUNE RESPONSE;
TUMOR;
BINDING AFFINITY;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CELL FUNCTION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
IMMUNOLOGICAL TOLERANCE;
MALIGNANT NEOPLASTIC DISEASE;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
RNA SEQUENCE;
SHORT SURVEY;
T LYMPHOCYTE;
TARGET CELL;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR MICROENVIRONMENT;
IMMUNOLOGY;
MELANOMA;
ANTIGENS, NEOPLASM;
EPITOPES, T-LYMPHOCYTE;
HLA-A2 ANTIGEN;
HUMANS;
MELANOMA;
RECEPTORS, ANTIGEN, T-CELL;
|
EID: 84975128703
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aag1547 Document Type: Short Survey |
Times cited : (5)
|
References (10)
|